| Attribute |
Value |
| 52 Week Change |
-0.39935064 |
| Address1 |
1,200 Brickell Avenue |
| Address2 |
Suite 1950 #1183 |
| All Time High |
7.98 |
| All Time Low |
0.51 |
| Ask |
1.19 |
| Ask Size |
2 |
| Average Daily Volume10 Day |
69,820 |
| Average Daily Volume3 Month |
119,459 |
| Average Volume |
119,459 |
| Average Volume10Days |
69,820 |
| Beta |
1.493 |
| Bid |
0.6422 |
| Bid Size |
2 |
| Book Value |
0.222 |
| City |
Miami |
| Compensation As Of Epoch Date |
1,767,139,200 |
| Country |
United States |
| Crypto Tradeable |
0 |
| Currency |
USD |
| Current Price |
0.9097 |
| Current Ratio |
82.156 |
| Custom Price Alert Confidence |
HIGH |
| Date Short Interest |
1,782,777,600 |
| Day High |
0.9331 |
| Day Low |
0.9001 |
| Display Name |
MIRA Pharmaceuticals |
| Ebitda Margins |
0.0 |
| Enterprise Value |
28,820,944 |
| Eps Forward |
-0.41 |
| Eps Trailing Twelve Months |
-1.27 |
| Esg Populated |
0 |
| Exchange |
NCM |
| Exchange Data Delayed By |
0 |
| Exchange Timezone Name |
America/New_York |
| Exchange Timezone Short Name |
EDT |
| Fifty Day Average |
0.98422 |
| Fifty Day Average Change |
-0.07452005 |
| Fifty Day Average Change Percent |
-0.07571483 |
| Fifty Two Week Change Percent |
-39.935066 |
| Fifty Two Week High |
2.45 |
| Fifty Two Week High Change |
-1.5403001 |
| Fifty Two Week High Change Percent |
-0.62869394 |
| Fifty Two Week Low |
0.896 |
| Fifty Two Week Low Change |
0.013699949 |
| Fifty Two Week Low Change Percent |
0.015290121 |
| Fifty Two Week Range |
0.896 - 2.45 |
| Financial Currency |
USD |
| First Trade Date Milliseconds |
1,691,069,400,000 |
| Float Shares |
35,027,931 |
| Forward Eps |
-0.41 |
| Forward P E |
-2.2187805 |
| Free Cashflow |
-428,220 |
| Full Exchange Name |
NasdaqCM |
| Gmt Off Set Milliseconds |
-14,400,000 |
| Gross Margins |
0.0 |
| Has Pre Post Market Data |
1 |
| Held Percent Insiders |
0.16714 |
| Held Percent Institutions |
0.05025 |
| Implied Shares Outstanding |
42,022,087 |
| Industry |
Drug Manufacturers - General |
| Industry Disp |
Drug Manufacturers - General |
| Industry Key |
drug-manufacturers-general |
| Ipo Expected Date |
2,023-08-03 |
| Language |
en-US |
| Last Fiscal Year End |
1,767,139,200 |
| Long Business Summary |
MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.S., Canadian, and Mexican rights for Ketamir-2, a next-generation oral NMDA receptor modulator, that has completed a Phase 1 clinical trial. It also offers oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia; and SKNY-1, that is in preclinical stage for obesity and nicotine dependence. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is based in Miami, Florida. |
| Long Name |
MIRA Pharmaceuticals, Inc. |
| Market |
us_market |
| Market Cap |
38,227,492 |
| Market State |
PRE |
| Max Age |
86,400 |
| Message Board Id |
finmb_1793899557 |
| Most Recent Quarter |
1,774,915,200 |
| Net Income To Common |
-31,365,680 |
| Next Fiscal Year End |
1,798,675,200 |
| Non Diluted Market Cap |
38,618,297 |
| Open |
0.93 |
| Operating Cashflow |
-4,232,925 |
| Operating Margins |
0.0 |
| Payout Ratio |
0.0 |
| Phone |
786 432 9792 |
| Previous Close |
0.9245 |
| Price Hint |
4 |
| Price To Book |
4.097748 |
| Profit Margins |
0.0 |
| Quick Ratio |
81.966 |
| Quote Source Name |
Nasdaq Real Time Price |
| Quote Type |
EQUITY |
| Recommendation Key |
none |
| Region |
US |
| Regular Market Change |
-0.0148 |
| Regular Market Change Percent |
-1.60087 |
| Regular Market Day High |
0.9331 |
| Regular Market Day Low |
0.9001 |
| Regular Market Day Range |
0.9001 - 0.9331 |
| Regular Market Open |
0.93 |
| Regular Market Previous Close |
0.9245 |
| Regular Market Price |
0.9097 |
| Regular Market Time |
1,783,972,800 |
| Regular Market Volume |
34,825 |
| Return On Assets |
-1.12658 |
| Return On Equity |
-1.84323 |
| Sand P52 Week Change |
0.20847368 |
| Sector |
Healthcare |
| Sector Disp |
Healthcare |
| Sector Key |
healthcare |
| Shares Outstanding |
42,022,087 |
| Shares Percent Shares Out |
0.0045 |
| Shares Short |
189,322 |
| Shares Short Previous Month Date |
1,780,012,800 |
| Shares Short Prior Month |
368,301 |
| Short Name |
MIRA Pharmaceuticals, Inc. |
| Short Percent Of Float |
0.0049 |
| Short Ratio |
1.91 |
| Source Interval |
15 |
| State |
FL |
| Symbol |
MIRA |
| Total Cash |
9,406,549 |
| Total Cash Per Share |
0.224 |
| Total Debt |
0 |
| Tradeable |
0 |
| Trailing Annual Dividend Rate |
0.0 |
| Trailing Annual Dividend Yield |
0.0 |
| Trailing Eps |
-1.27 |
| Trailing Peg Ratio |
None |
| Triggerable |
1 |
| Two Hundred Day Average |
1.23858 |
| Two Hundred Day Average Change |
-0.32888 |
| Two Hundred Day Average Change Percent |
-0.2655299 |
| Type Disp |
Equity |
| Volume |
34,825 |
| Website |
https://mirapharmaceuticals.com |
| Zip |
33,131 |